Gilead Sciences (GILD) Stock Price, Quote, News & History | Benzinga

Gilead Sciences Inc (GILD) Stock Price, Quote, News & History

GILDNASDAQ

Trade with Public

Trade with Public

$127.75

-2.65-2.03%

At close: Apr 27, 5:00 PM EST

$127.75

N/A

After Hours: 4:35 PM EST

Earnings: Q1 2026 Earnings in 10 days from now on Thu May 7th, after the market close

OverviewNews Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$128.80

Close

$127.75

Volume / Avg.

8.04M / 6.79M

Day Range

$127.64 - $130.33

52 Wk Range

93.37 - 157.29

Market Cap

$158.56B

P/E Ratio

19.23

Dividend Yield

2.52%

Exchange

NASDAQ

RSI

27

Short Interest

1.83%

Days to Cover

4.74

Recent Gilead Sciences Inc News

What's Going On With Arcus Biosciences Stock On Wednesday?

Arcus Biosciences halts STAR-121 lung cancer trial after futility review while Gilead Science declines option extension.

Vandana Singh

Gilead Expands Partnership With Tempus AI To Power Cancer Discoveries

Tempus AI (TEM) shares up 3.6% on expanded Gilead oncology deal. Explore technical support levels, ALERT trial success, and analyst ratings.

Lekha Gupta

Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline

Gilead expands Tempus AI deal and licenses Kymera's KT-200, advancing oncology pipeline with data, analytics and drug development.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

10.02B

Investing Cash Flow (TTM)

-4.79B

Financing Cash Flow (TTM)

-7.75B

Free Cash Flow (TTM)

9.46B

Capital Expenditure (TTM)

-563.00M

Net Change in Cash (TTM)

-2.52B

Analyst Trends and Forecast

2

Dec 25

6

Jan

5

1

Feb

1

Mar

2

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$177.18B

PE Ratio (TTM)

19.23

PE Ratio (FWD)

14.93

PEG Ratio (TTM)

0.36

PS Ratio (TTM)

5.56

PB Ratio (TTM)

7.13

Earnings Yield % (TTM)

5.20%

Earnings Yield % (FWD)

6.70%

EV / EBITDA (TTM)

13.05

Price / EBITDA (TTM)

12.05

Price / Free Cash Flow (TTM)

17.31

Book Value / Share

$18.29

Company Debt

Total Debt

$24.94B

LT Debt

$22.13B

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$1.79B

Total Cash

$7.56B

Debt to Equity

1.10

Issuance of Debt (TTM)

-$1.79B

Repayment of Debt (TTM)

-$1.79B

Key Statistics

Open

$128.80

Close

$127.75

Volume / Avg.

8.04M / 6.79M

Day Range

$127.64 - $130.33

52 Wk Range

93.37 - 157.29

Market Cap

$158.56B

P/E Ratio

19.23

Dividend Yield

2.52%

Exchange

NASDAQ

RSI

27

Short Interest

1.83%

Days to Cover

4.74

About

Sector

Health Care

Industry

Biotechnology

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Gilead Sciences (GILD) stock?

A

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Gilead Sciences (GILD) competitors?

A

Other companies in Gilead Sciences’s space includes: BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Amgen Inc (NASDAQ:AMGN).

Q

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

A

Gilead Sciences has a consensus price target of $130.23.

Q

What is the current price for Gilead Sciences (GILD)?

A

The stock price for Gilead Sciences (NASDAQ: GILD) is $127.75 last updated April 27, 2026 at 4:35 PM EDT.

Q

Does Gilead Sciences (GILD) pay a dividend?

A

There are no upcoming dividends for Gilead Sciences.

Q

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

A

Gilead Sciences does not have any upcoming earnings scheduled.

Q

Is Gilead Sciences (GILD) going to split?

A

There is no upcoming split for Gilead Sciences.

Q

What sector and industry does Gilead Sciences (GILD) operate in?

A

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

BeOne Medicines Ltd

Neurocrine Biosciences Inc

Ionis Pharmaceuticals Inc

Roivant Sciences Ltd

United Therapeutics Corp